Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis

Epilepsia

Volumn 51, Issue 1, 2010, Pages 7-26

  Beyenburg, Stefan ^a   Stavem, Knut ^b,c   Schmidt, Dieter ^d  

^a Department of Neurology   (United Kingdom)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Epilepsy Research Group   (Germany)

Author keywords

Antiepileptic drugs; Placebo; Placebo corrected seizure outcome; Refractory epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ESLICARBAZEPINE ACETATE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LOSIGAMONE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; PRIMIDONE; RETIGABINE; RUFINAMIDE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CHILD; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INTRACTABLE EPILEPSY; META ANALYSIS; PLACEBO EFFECT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CHILD; DRUG RESISTANCE; EPILEPSY; FEMALE; HUMANS; MALE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 76249085581     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02299.x     Document Type: Review

References (75)

1. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B 1994) Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 35 : 795 801.
2. Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, Garofalo E, Gabapentin Paediatric Study Group 1999) Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Epilepsia 40 : 1147 1154.
3. Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S, Pregabalin 1008-011 International Study Group 2004) Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 : 20 27.
4. Barcs G, Walker EB, Elger CE, Scaramelli A, Stefan H, Sturm Y, Moore A, Flesch G, Kramer L, DeSouza J 2000) Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 41 : 1597 1607.
5. Bauer J, Dienel A, Elger CE, Losigamone Study Group 2001) Losigamone add-on therapy in partial epilepsy: a placebo-controlled study. Acta Neurol Scand 103 : 226 230.
6. Baulac M, Klement S, Losigamone Study Group 2003) Efficacy and safety of Losigamone in partial seizures: a randomized double-blind study. Epilepsy Res 55 : 177 1789.
7. Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, Schmidt D, Ried S, Reife R, Kramer L, Pledger G, Karim R 1996) Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 37 : 539 543. (Pubitemid 26169188)
8. Ben-Menachem E, Falter U, European Levetiracetam Study Group 2000) Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 41 : 1276 1283.
9. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD 2007) Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48 : 1308 1317.
10. Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U, Levetiracetam N01057 Study Group 2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69 : 1751 1760.
11. Betts T, Waegemans T, Crawford P 2000) A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 9 : 80 87.
12. Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA, Pregabalin 1008-009 Study Group 2005) Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64 : 475 480.
13. Birbeck GL, Hays RD, Cui X, Vickrey BG 2002) Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 43 : 535 538.
14. Biton V, Montouris GD, Ritter F, Riviello JJ, Reife R, Lim P, Pledger G 1999) A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 52 : 1330 1337.
15. Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA 2005) Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 65 : 1737 1743.
16. Boon P, Chauvel P, Pohlmann-Eden B, Otoul C, Wroe S 2002) Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy. Epilepsy Res 48 : 77 89.
17. Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C 2005) Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 46 : 31 41.
18. Bruni J, Guberman A, Vachon L, Desforges C, The Canadian Vigabatrin Study Group 2000) Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. Seizure 9 : 224 232.
19. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I 2005) Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55 : 236 242.
20. Chapell R, Reston J, Snyder D (2003) Management of treatment-resistant epilepsy. Evidence report/technology assessment No.77. AHRQ Publication No.03-0028. Part 1. Agency for Healthcare Research and Quality, Rockville, MD, pp. 1 323.
21. Chiron C, Dumas C, Jambaqué I, Mumford J, Dulac O 1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26 : 389 395.
22. Dean C, Mosier M, Penry K 1999) Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures. Epilepsia 40 : 74 82.
23. DerSimonian R, Laird N 1986) Meta-analysis in clinical trials. Control Clin Trials 7 : 177 188.
24. Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E, Womble G, Risner M, Manasco P 1999) A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology 53 : 1724 1731.
25. Egger M, Davey-Smith G, Schneider M, Minder C 1997) Bias in meta-analysis detected by a single, graphical test. BMJ 315 : 629 634.
26. Elger CE, Brodie MJ, Anhut H, Lee CM, Barrett JA 2005) Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46 : 1926 1936.
27. Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P 2007) Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 48 : 497 504.
28. Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G 1999) A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 52 : 1338 1344.
29. Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, Karim RM 1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 46 : 1684 1690.
30. Faught E, Ayala R, Montouris GG, Leppik IE, Zonisamide 922 Trial Group 2001) Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57 : 1774 1779.
31. Faught E 2004) Treatment of refractory primary generalized epilepsy. Rev Neurol Dis 1 (Suppl 1 S34 S43.
32. French JA, Mosier M, Walker S, Sommerville K, Sussman N, Vigabatrin Protocol 024 Investigative Cohort 1996) A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Neurology 46 : 54 61.
33. French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA 2003) Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60 : 1631 1637.
34. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr., Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr., Sachdeo RC, Beydoun A, Glauser TA, Therapeutics Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society 2004) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment. Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 : 1261 1273. (Pubitemid 38526036)
35. Gazzola DM, Balcer LJ, French JA 2007) Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 48 : 1303 1307.
36. Glauser TA, Nigro M, Sachdeo R, Psteris LAS, Weinstein S, Abou-Khalil B, Frank LM, Grinspan A, Guarino T, Bettis D, Kerrigan J, Geoffrey G, Mandelbaum D, Jacobs T, Mesenbrink P, Kramer L, D'Souza J 2000) Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 54 : 2237 2244.
37. Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Oman CB, Gauer LJ, Lu Z, N159 Study Group 2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66 : 1654 1660.
38. Grant R, Shorvon SD 2000) Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy Res 42 : 89 95.
39. Higgins JPT, Thompson SG, Decks JJ 2003) Measuring inconsistency in meta-analyses. Brit Med J 327 : 557 560.
40. Higgins JT, Higgins JPT 2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37 : 1158 1160.
41. Kälviäinen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K 1998) A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Epilepsy Res 30 : 31 40.
42. Kerr MP, Baker GA, Brodie MJ 2005) A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Epilepsy Behav 7 : 472 480.
43. Korean Topiramate Study Group 1999) Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Epilepsia 40 : 1767 1774.
44. Kwan P, Brodie MJ 2000) Early identification of refractory epilepsy. N Engl J Med 342 : 314 319.
45. Löscher W, Schmidt D 2006) New Horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res 69 : 183 272.
46. Luciano AL, Shorvon SD 2007) Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 62 : 375 381.
47. Maguire MJ, Hemming K, Hutton JL, Marson AG 2008) Overwhelming heterogeneity in systematic reviews of observational anti-epileptic drugs. Epilepsy Res 80 : 201 212.
48. Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG 1993) Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 43 : 2284 2291.
49. Messenheimer J, Ramsay RE, Willmore LJ, Leroy RF, Zielinski JJ, Mattson R, Pellock JM, Valakas AM, Womble G, Risner M 1994) Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 35 : 113 121.
50. Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P 1997) Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 337 : 1807 1812.
51. Naritoku DK, Warnock CR, Messenheimer JA, Borgohain R, Evers S, Guekht AB, Karlov VA, Lee BI, Pohl LR 2007) Lamotrigine extended-release as adjunctive therapy for partial seizures. Neurology 69 : 1610 1618.
52. Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J, N 166 Levetiracetam Study Group 2008) Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70 : 607 616.
53. Oken BS 2008) Placebo effects: clinical aspects and neurobiology. Brain 131 : 2812 2823.
54. Pålhagen S, Canger R, Henriksen O, van Parys JA, Riviere ME, Karolchyk MA 2001) Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy. Epilepsy Res 43 : 115 1124.
55. Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM, 205 Study Group 2007) Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 68 : 1197 1204.
56. Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim G 1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology 46 : 1678 1683. (Pubitemid 26185792)
57. Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P 2008) Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 5 : e166.
58. Sachdeo RC, Leroy RF, Krauss GL, Drake Me Jr., Green PM, Leppik IE, Shu VS, Ringham GL, Sommerville KW 1997) Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group. Arch Neurol 54 : 595 601.
59. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G 1999) A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 52 : 1882 1887.
60. Sackellares JC, Ramsay RE, Wilder BJ, Browne TR III., Shellenberger MK 2004) Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 45 : 610 617.
61. Schiller Y, Najjar Y 2008) Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 70 : 54 65.
62. Schmidt D, Jacob R, Loiseau P, Deisenhammer E, Klinger D, Despland A, Egli M, Bauer G, Stenzel E, Blankenhorn V 1993) Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 15 : 67 73.
63. Schmidt D, Löscher W 2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46 : 858 877. (Pubitemid 40847354)
64. Selwa LM, Schmidt SL, Malow BA, Beydoun A 2003) Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy. Epilepsia 44 : 1568 1572.
65. Sharief M, Viteri C, Ben-Menachem E, Weber M, Reife R, Pledger G, Karim R 1996) Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 25 : 217 224. (Pubitemid 26394543)
66. Shorvon SD, Löwenthal A, Janz D, Bielen E, Loiseau P 2000) Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 41 : 1179 1186.
67. Sillanpää M, Schmidt D 2006) Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 61 : 7 24.
68. Tassinari CA, Michelucci R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, Dam M, Reife R, Pledger G, Karim R 1996) Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 37 : 763 768. (Pubitemid 26276946)
69. The US Gabapentin Study Group No. 5 1993) Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 43 : 2292 2298.
70. Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA 2006) Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Pediatrics 118 : e371 e378.
71. Tsai JJ, Yen DJ, Hsih MS, Chen SS, Hiersemenzel R, Edrich P, Lai CW 2006) Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study. Epilepsia 47 : 72 81.
72. UK Gabapentin Study Group 1990) Gabapentin in partial epilepsy. Lancet 335 : 1114 1117.
73. Uthman BM, Rowan AJ, Ahmann PA, Leppik JE, Schachter SC, Sommerville KW, Shu V 1998) Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol 55 : 56 62.
74. Yamauchi T, Kaneko S, Yagi K, Sase S 2006) Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study. Psychiatry Clin Neurosci 60 : 507 515.
75. Yen DJ, Yu HY, Guo YC, Chen C, Yiu CH, Su MS 2000) A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy. Epilepsia 41 : 1162 1166.